Inhibitors of connexin and pannexin channels as potential therapeutics
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
&NA; While gap junctions support the exchange of a number of molecules between neighboring cells, connexin hemichannels provide communication between the cytosol and the extracellular environment of an individual cell. The latter equally holds true for channels composed of pannexin proteins, which display an architecture reminiscent of connexin hemichannels. In physiological conditions, gap junctions are usually open, while connexin hemichannels and, to a lesser extent, pannexin channels are typically closed, yet they can be activated by a number of pathological triggers. Several agents are available to inhibit channels built up by connexin and pannexin proteins, including alcoholic substances, glycyrrhetinic acid, anesthetics and fatty acids. These compounds not always strictly distinguish between gap junctions, connexin hemichannels and pannexin channels, and may have effects on other targets as well. An exception lies with mimetic peptides, which reproduce specific amino acid sequences in connexin or pannexin primary protein structure. In this paper, a state‐of‐the‐art overview is provided on inhibitors of cellular channels consisting of connexins and pannexins with specific focus on their mode‐of‐action and therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pannexin 1 channels mediate ‘find-me’ signal release and membrane permeability during apoptosis
Chekeni, F. B., Elliott, M. R., Sandilos, J. K., Walk, S. F., Kinchen, J. M., Lazarowski, E. R., Armstrong, A. J., Penuela, S., Laird, D. W., Salvesen, G. S., et al. (2010) · Nature · doi:10.1038/nature09413 · Cited by 1,120
siRNA versus miRNA as therapeutics for gene silencing
Lam, J. K. W., Chow, M. Y. T., Zhang, Y., & Leung, S. W. S. (2015) · Molecular Therapy — Nucleic Acids · doi:10.1038/mtna.2015.23 · Cited by 1,081 · cited 1×
“Subsequently, the endonuclease Argonaute component of the RISC cleaves the passenger strand of siRNA, while the guide strand can target a specific mRNA through base-pairing to influence its activity (Lam et al., 2015).”
Takeuchi, H., Jin, S., Wang, J., Zhang, G., Kawanokuchi, J., Kuno, R., Sonobe, Y., Mizuno, T., & Suzumura, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600504200 · Cited by 749 · cited 2×
“…Rash, 2000) Microglial cells Cx26, Cx32, Panx1 (Eugenín et al., 2001; Garg et al., 2005; Kielian, 2008; Parenti et al., 2002; Penuela et al., 2013; Takeuchi et al., 2006) Oligodendrocytes Cx32, Cx47, Cx29 (Altevogt, Kleopa, Postma, Scherer, & Paul, 2002; Dermietzel, et al., 1989; Odermatt, et…”
Csak, T., Ganz, M., Pespisa, J., Kodys, K., Dolganiuc, A., & Szabo, G. (2011) · Hepatology · doi:10.1002/hep.24341 · Cited by 645 · cited 2×
“, 2012; Xiao, Waldrop, Khimji, & Kilic, 2012) and inflammation (Brough, Pelegrin, & Rothwell, 2009; Crespo Yanguas et al., 2017; Csak et al., 2011; Ganz, Csak, Nath, & Szabo, 2011; Marina-García et al., 2008) has been well documented.”
Potent block of Cx36 and Cx50 gap junction channels by mefloquine
Cruikshank, S. J., Hopperstad, M., Younger, M., Connors, B. W., Spray, D. C., & Srinivas, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402044101 · Cited by 350
Little, T. L., Beyer, E. C., & Duling, B. R. (1995) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1995.268.2.h729 · Cited by 292
Nagasawa, K., Chiba, H., Fujita, H., Kojima, T., Saito, T., Endo, T., & Sawada, N. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20647 · Cited by 255 · cited 2×
“…Penuela et al., 2013; Takeuchi & Suzumura, 2014) Blood-brain barrier endothelial cells Cx37, Cx40, Cx43 (De Bock et al., 2014; Little et al., 1995; Nagasawa et al., 2006; Traub,et al., 1998) Blood-brain barrier pericytes Cx37, Cx40, Cx43 (De Bock et al., 2014; Little et al., 1995; Nagasawa et…”
Danesh-Meyer, H. V., Kerr, N. M., Zhang, J., Eady, E. K., O'Carroll, S. J., Nicholson, L. F. B., Johnson, C. S., & Green, C. R. (2012) · Brain · doi:10.1093/brain/awr338 · Cited by 179 · cited 4×
“Over the past decade, several peptides have been demonstrated to block Cx HCs and Panx channels, including 43Gap26 (Wang et al., 2013), 43Gap27 (De Bock et al., 2011), Peptide5 (Danesh-Meyer et al., 2012), 43Gap19 (Wang et al., 2013), 32Gap24 (De Vuyst et al., 2006) and 10Panx1 (Pelegrin & Surprenant, 2007).”
InfluentialCarbenoxolone Inhibition of Voltage-Gated Ca Channels and Synaptic Transmission in the Retina
Vessey, J. P., Lalonde, M. R., Mizan, H. A., Welch, N. C., Kelly, M. E. M., & Barnes, S. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00148.2004 · Cited by 178 · cited 2×
“Specifically, carbenoxolone blocks voltage-gated Ca2+ currents in the retina (IC50 48 µM) (Vessey et al., 2004), homomeric Panx1 and heteromeric Panx1/Panx2 channels in X. laevis oocytes (IC50 5 µM) (Bruzzone et al., 2005), Panx1 channels in mouse (IC50 4 µM) and human embryonic kidney (HEK)293…”
Cited by
Central Nervous System Targets: Glial Cell Mechanisms in Chronic Pain
Donnelly, C. R., Andriessen, A. S., Chen, G., Wang, K., Jiang, C., Maixner, W., & Ji, R.-R. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00905-7 · Cited by 301
Therapeutic strategies targeting connexins
Laird, D. W., & Lampe, P. D. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.138 · Cited by 219
Ribeiro-Rodrigues, T. M., Martins-Marques, T., Morel, S., Kwak, B. R., & Girão, H. (2017) · Journal of Cell Science · doi:10.1242/jcs.200667 · Cited by 203
“…– the gap junction plaque – emerging evidence suggests that these structures have an active role in various pathological conditions, including inflammation, liver, lung and heart disease, wound healing, ischaemia–reperfusion lesion and atherosclerosis (for a review see Willebrords et al., 2017).”
BackgroundGlial Connexins and Pannexins in the Healthy and Diseased Brain
Giaume, C., Naus, C. C., Sáez, J. C., & Leybaert, L. (2021) · Physiological Reviews · doi:10.1152/physrev.00043.2018 · Cited by 154
Metadata
- Authors
- Willebrords, J., Maes, M., Crespo Yanguas, S., & Vinken, M.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2017-12
- Volume
- 180
- Pages
- 144-160
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2736010006
- Cited by
- 160
- References
- 9
- FWCI
- 6.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibitors of connexin and pannexin channels as potential therapeutics. https://app.cochat.ai/papers/10.1016/j.pharmthera.2017.07.001
- The paper
- Willebrords, J., Maes, M., Crespo Yanguas, S., & Vinken, M. (2017). Inhibitors of connexin and pannexin channels as potential therapeutics. Pharmacology & Therapeutics. https://doi.org/10.1016/j.pharmthera.2017.07.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.